Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2003
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003057834A3 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
12/31/2003WO2003045997A3 Fusion proteins containing tlp peptides
12/31/2003WO2003039486A3 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
12/31/2003WO2003037265A3 Method of treating viral infections
12/31/2003WO2003035004A9 Immunotherapy for reversing immune suppression
12/31/2003WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2002077648A3 Pathogenic and commensal vaccine antigens
12/31/2003WO2002074333A3 Mycobacterial extracts used for treating allergy
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070004A3 Papillomavirus vaccines
12/31/2003WO2002042325A3 Cyp1b1 nucleic acids and methods of use
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464789A Vaccine against the influenza virus and method for producing said virus vaccine
12/31/2003CN1464062A Expression vector pBVTB, its construction method and use in HCV vaccin research
12/31/2003CN1463985A Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom
12/31/2003CN1463748A A novel highly effective immunologic adjuvant originated from plants, method for making the same and use thereof
12/31/2003CN1463747A A Newcastle disease vaccine and method for preparing the same
12/31/2003CN1132631C Veterinary medicine for treating infective serositis of duck and its preparing process
12/31/2003CN1132630C Vaccine adjuvants
12/31/2003CN1132629C Composition of tyrosine and polymerised allergen
12/31/2003CN1132628C 多价在卵内接种的禽疫苗 Multivalent in ovo vaccination of poultry vaccines
12/31/2003CN1132627C Solid fermentation process of producing waxy microecological bacillus prepn
12/31/2003CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
12/31/2003CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2491070A1 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/31/2003CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
12/31/2003CA2490747A1 Method for generating monoclonal antibodies
12/31/2003CA2490449A1 Adjuvant-free peptide vaccine
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2489907A1 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins
12/31/2003CA2489905A1 Osteopontin, oligodendrocytes and myelination
12/31/2003CA2489540A1 Methods of treating and preventing colitis involving il-13 and nk-t cells
12/31/2003CA2489523A1 Administration of therapeutic viruses
12/31/2003CA2489052A1 Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
12/31/2003CA2488856A1 Packaged virus-like particles for use as adjuvants: method of preparation and use
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670463 Polynucleotides that encode carcinoma proteins or antibodies or immune system cells specific for such proteins.
12/30/2003US6670453 Crosslinking, agglutination, purification
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670181 Compositions and methods for treating viral infections
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670114 Screening for molecules which modulate the binding between HCV and human apolipoprotein B
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669947 Stratified and cryogenically stored vaccines, process for their preparation
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669945 Universal T-cell epitopes for anti-malarial vaccines
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669940 For immunizing an animal against liver abscesses caused by F. necrophorum
12/30/2003US6669939 Peptide mixtures which are mimetics of kaposi sarcoma associated herpes virus (KSHV) proteins, and biological conjugates, used in kits for diagnosis or detection of antibodies or infections of DNA viruses
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2163641C Multiple sclerosis virus
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2093806C Method of treating or preventing type 1 diabetes by oral administration of insulin
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/30/2003CA2067862C Stable pura vectors and uses thereof
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/25/2003WO2003106682A1 Hla-a24-restricted cancer antigen peptide
12/25/2003WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236211 Method according to the invention enables both decreasing the immunostimulatory effect for antisense applications, as well as increasing the immunostimulatory effect for immunotherapy applications
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030235903 Forming vaccine; parasiticide; forming antibodies
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235897 Immunological control of beta-amyloid levels in vivo
12/25/2003US20030235891 Method for generating monoclonal antibodies
12/25/2003US20030235869 Biological products
12/25/2003US20030235842 Map
12/25/2003US20030235835 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
12/25/2003US20030235821 Novel Human proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030235818 Identifying amino acid sequences which mimic epitopes of target proteins such as shigella toxin, hepatitis viral coat protein and anthrax lethal factor for development of genetic vacines
12/25/2003US20030235593 Kits; vaccines
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235591 Comprises hepatitis B surface antigens
12/25/2003US20030235590 Hepatitis B virus (hbv) purified in presence of cysteine
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235583 Combined use of a modulator of CD3 and a beta cell resting compound
12/25/2003US20030235582 Anti-IGF-I receptor antibody
12/25/2003US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence
12/25/2003US20030235556 Combination IL-2/anti-HER2 antibody therapy for cancers characterized by overexpression of the HER2 receptor protein
12/25/2003US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines
12/25/2003US20030235534 Methods and compositions for radioimmunotherapy of brain and CNS tumors
12/24/2003WO2003106974A2 Diagnosis and treatment of chemoresistant tumors
1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 1823